Literature DB >> 18828523

Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.

Samuel C Bukantz1, Andrew S Bagg, Richard F Lockey.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18828523

Source DB:  PubMed          Journal:  Clin Allergy Immunol        ISSN： 1075-7910


× No keyword cloud information.
  6 in total

1.  Cutaneous vaccination with coated microneedles prevents development of airway allergy.

Authors:  Akhilesh Kumar Shakya; Chang Hyun Lee; Harvinder Singh Gill
Journal:  J Control Release       Date:  2017-08-15       Impact factor: 9.776

Review 2.  Chinese Guideline on allergen immunotherapy for allergic rhinitis.

Authors:  Yixiao Bao; Jianjun Chen; Lei Cheng; Yinshi Guo; Suling Hong; Weijia Kong; He Lai; Houyong Li; Huabin Li; Jing Li; Tianying Li; Xiaoping Lin; Shixi Liu; Zheng Liu; Hongfei Lou; Juan Meng; Qianhui Qiu; Kunling Shen; Wei Tang; Zezhang Tao; Chengshuo Wang; Xiangdong Wang; Qingyu Wei; Li Xiang; Hua Xie; Yu Xu; Gehua Zhang; Yuan Zhang; Yiwu Zheng; Yuxiang Zhi; Dehua Chen; Haiyu Hong; Quansheng Li; Lin Liu; Yifan Meng; Nan Wang; Yihui Wang; Yue Zhou; Luo Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients.

Authors:  Oliver Pfaar; Angelika Sager; Douglas S Robinson
Journal:  Pediatr Allergy Immunol       Date:  2015-05       Impact factor: 6.377

4.  A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol.

Authors:  L Klimek; J Uhlig; R Mösges; K Rettig; O Pfaar
Journal:  Allergy       Date:  2014-10-06       Impact factor: 13.146

5.  Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.

Authors:  Urai Chaisri; Anchalee Tungtrongchitr; Nitaya Indrawattana; Panisara Meechan; Watchara Phurttikul; Natt Tasaniyananda; Nawannaporn Saelim; Wanpen Chaicumpa; Nitat Sookrung
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

6.  Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age.

Authors:  Mário Morais-Almeida; Cristina Arêde; Graça Sampaio; Luis Miguel Borrego
Journal:  Asia Pac Allergy       Date:  2016-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.